API

Active Pharmaceutical Ingredients (API), popularly speaking, are the raw materials of medicines, only pharmaceutical raw materials are processed into pharmaceutical preparations , can they become medicines available for clinical use, so drugs we usually eat are the finished drugs through processing. Active Pharmaceutical Ingredients based on its sources can be divided into two major categories ,including chemical synthetic drugs and natural chemical drugs. Chemical synthetic drugs can be divided into organic synthetic drugs and inorganic synthetic drugs. Inorganic synthetic drugs are inorganic compounds ( very few is element), such as aluminum hydroxide, magnesium trisilicate which are used for the treatment of gastric and duodenal ulcers ; organic synthetic drugs are mainly composed of drugs made by basic organic chemical raw materials, through a series of organic chemical reactions (such as aspirin, chloramphenicol, caffeine, etc.). Natural chemical drugs ,based on its sources,can be divided into two categories including biochemical drugs and plant chemical drugs. Antibiotics are generally made by the microbial fermentation, which belongs to the biochemistry category. A variety of semi-synthetic antibiotics occurs in recent years,which are biosynthesis and chemical synthesis combining products.Among active Pharmaceutical Ingredients, the organic synthetic drugs varieties, yields and values have the largest proportion,which are the main pillars of the chemical and pharmaceutical industries. The quality of active Pharmaceutical Ingredients decides whether the formulation is good or bad , so its quality standards are very strict ,countries in the world have developed national pharmacopoeia standards and strict quality control methods for its widely used active Pharmaceutical ingredients.

The uses and side effects of Valsartan

Valsartan is an angiotensin II type 1 receptor blocker (ARB). This drug is commonly combinated with Sacubitril.

Nov 9,2023  API

A sulfonylurea oral hypoglycemic agent: Gliclazide

Gliclazide is a second-generation, sulfonylurea oral hypoglycemic agent. It can improve blood clotting and postpone the complications of diabetes, and is commonly used in the diabetic II treatment.

Nov 9,2023  API

Azithromycin vs Amoxicillin

Both Azithromycin and Amoxicillin are considered broad-spectrum antibiotics, which means they treat a wide range of infections, but azithromycin treats a longer list than amoxicillin.

Nov 8,2023  API

The uses and biological activity of Candesartan cilexetil

Candesartan cilexetil is converted completely into the active metabolite candesartan during gastrointestinal absorption.

Nov 8,2023  API

The Pharmacokinetics and toxicity of Mesalazine

Mesalazine is a medication commonly used for the treatment of inflammatory bowel disease. Over the years, there has been significant research on the toxicity and pharmacokinetics of this drug.

Nov 7,2023  API

A useful anti-inflammatory agent: Mesalazine

Mesalazine is an anti-inflammatory agent, structurally related to salicylates, which is active in inflammatory bowel disease.

Nov 7,2023  API

The applications and side effects of Entecavir

Entecavir is an analog of 2′-deoxyguanosine. This compound is approved for the treatment of hepatitis B infection with compensated or decompensated liver disease in adults.

Nov 6,2023  API

Stanolone: biochemistry, physiology, and clinical implications

Stanolone, synthesized via SRD5A, has diverse clinical applications in hormone-related disorders and cancer treatment.

Nov 6,2023  API

NADP, Disodium Salt: physiological role, activities and applications

NADP, Disodium Salt is a vital coenzyme in cellular metabolism, redox reactions, and gene expression regulation with promising therapeutic potential.

Nov 6,2023  API

N-Glycyl-L-tyrosine: activities and clinical applications

N-Glycyl-L-tyrosine demonstrates potent antioxidant and anti-inflammatory properties, making it a promising therapeutic agent with clinical applications.

Nov 3,2023  API
Prev12345678910...Next>  Go to Page